SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435908. A total of 1 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $93,317,000 | +969.7% | 540,000 | +611.5% | 0.02% | +950.0% |
| Q4 2014 | $8,724,000 | +556.9% | 75,900 | +792.9% | 0.00% | – |
| Q3 2014 | $1,328,000 | -97.8% | 8,500 | -98.3% | 0.00% | -100.0% |
| Q2 2014 | $61,675,000 | +20.6% | 500,000 | +1.3% | 0.02% | +14.3% |
| Q1 2014 | $51,157,000 | +15.2% | 493,750 | 0.0% | 0.01% | +7.7% |
| Q4 2013 | $44,408,000 | +34.5% | 493,750 | 0.0% | 0.01% | +30.0% |
| Q3 2013 | $33,022,000 | – | 493,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 493,750 | $33,022,000 | 0.01% |